Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a chance for a novel therapy of GABA-related disorders.

2021/41/B/NZ7/02825

Keywords

Descriptors

  • NZ7_014: Farmacja, farmakoterapia, farmakologia
  • NZ3_007: Przekaźnictwo sygnału
  • ST4_008: Chemia organiczna

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński, Collegium Medicum

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Dawid Marcin Panek

Number of co-investigators in the project: 11

Call

OPUS 21 – announced on 2021-03-15

Amount awarded
1 684 200 PLN
Project start date
2022-02-07
Project end date
2027-02-06
Project duration
60 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (3)

  1. Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies

    Authors:
    Dawid Panek, Anna Pasieka, Gniewomir Latacz, Paula Zaręba, Michał Szczęch, Justyna Godyń, Fabien Chantegreil, Florian Nachon, Xavier Brazzolotto, Anna Skrzypczak-Wiercioch, Maria Walczak, Magdalena Smolik, Kinga Sałat, Georg Höfner, Klaus Wanner, Anna Więckowska, Barbara Malawska
    Academic press:
    The European Journal of Medicinal Chemistry (year: 2023, volume: 249, pages: 115135), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2023.115135 – link to the publication
  2. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease

    Authors:
    Paula Zaręba, Kamil Łątka, Gabriela Mazur, Beata Gryzło, Anna Pasieka, Justyna Godyń, Dawid Panek, Anna Skrzypczak-Wiercioch, Georg C Höfner, Gniewomir Latacz, Maciej Maj, Alba Espargaró, Raimon Sabaté, Krzysztof Jóźwiak, Klaus T Wanner, Kinga Sałat, Barbara Malawska, Katarzyna Kulig, Marek Bajda
    Academic press:
    European Journal of Medicinal Chemistry (year: 2023, volume: 261, pages: 115832), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.ejmech.2023.115832 – link to the publication
  3. Multifunctional, Fluorene-Based Modulator of Cholinergic and GABAergic Neurotransmission as a Novel Drug Candidate for Palliative Treatment of Alzheimer's Disease

    Authors:
    Dawid Panek, Anna Pasieka, Jakub Jończyk, Milena Gawlińska, Paula Zaręba, Agata Siwek, Małgorzata Wolak, Barbara Mordyl, Monika Głuch-Lutwin, Gniewomir Latacz, Xavier Brazzolotto, Fabien Chantegreil, Florian Nachon, Jana Zdarova Karasova, Jaroslav Pejchal, Martin Mzik, Vit Sestak, Lukas Prchal, Jitka Odvarkova, Ondrej Soukup, Jan Korabecny, Ales Sorf, Marie Hamsikova, Lucie Zemanova, Lubica Muckova, Nela Vánova, Pola Dryja, Kinga Sałat, Georg Höfner, Klaus Wanner, Anna Więckowska, Barbara Malawska
    Academic press:
    Angewandte Chemie International Edition (year: 2024, volume: 64, pages: e202420510), Publisher: Willey
    Status:
    Published
    DOI:
    10.1002/anie.202420510 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski